| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $350.2M | +7.3% | +36.1% |
| Cost of Revenue | $200.6M | +4.8% | +34.6% |
| R&D Expense | $18.2M | -1.2% | +9.5% |
| SG&A Expense | $36.9M | -8.4% | -36.1% |
| Operating Income | $80.0M | +41.6% | +257.2% |
| Pre-tax Income | $8.1M | -62.6% | +109.4% |
| Income Tax | -$15.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $218.3M | +19.3% | +48.4% |
| Total Assets | $1.46B | +4.0% | +6.2% |
| Total Liabilities | $889.4M | +3.8% | +18.0% |
| Stockholders' Equity | $438.3M | +19.5% | -5.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $158.8M | — | — |
| Capital Expenditures | $10.8M | — | — |
| Investing Cash Flow | -$209.5M | — | — |
| Financing Cash Flow | $86.9M | — | — |
| Free Cash Flow | $148.0M | — | — |
| -405.5% |
| -32.0% |
| Net Income | $22.5M | +35.4% | +133.4% |
| EPS (Basic) | $0.27 | +35.0% | +129.0% |
| EPS (Diluted) | $0.23 | +15.0% | +124.7% |